AC

Alejandro Velando Crespo

Data Coordinator at OXON Epidemiology

Alejandro Velando Crespo has an extensive background in clinical data management and oncology clinical trials. With experience in various companies such as OXON Epidemiology, UICEC -SCREN, and Pivotal, Alejandro has demonstrated skills in data coordination, query management, and adherence to protocols and regulations. Alejandro's educational background includes a Master's degree in Clinical Trials Monitoring and Medical Affairs, as well as additional courses in Clinical Trial Management and Therapeutic Targets in Cellular Signaling. Overall, Alejandro is a dedicated professional with a strong foundation in biomedical research and clinical data management.

Location

Madrid, Spain

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


OXON Epidemiology

OXON Epidemiology is a European full-service Contract Research Organization (CRO) specialising in the generation of Real-World Evidence (RWE) via primary data collection, secondary data and hybrid observational studies, pragmatic trials, synthesis research, and data analysis and modelling of drugs and devices in all major therapeutic areas. OXON strives to be the Go-To leader in the design and implementation of outstanding observational studies. Our mission is to integrate methodological and statistical thinking and insights to maximize value and provide solutions for our clients. As a leader CRO, OXON provides a unique blend of quality science and operational experience to support pharmaceutical and medical devices companies worldwide to obtain high-quality RWE for Safety, Market Access, and Clinical Development for improving patients’ and public health: • Multi-country field, chart review and database epidemiological studies • Patient registries • Pragmatic Trials • Systematic Reviews & Meta-analysis • PASS and PAES studies • Risk minimisation studies • Risk management • Statistical signal detection & analysis • Quantitative benefit-risk analysis for CTD / PBRER • Patient reported outcomes • Health economics & modelling • Meta-analysis and Evidence strategy


Employees

11-50

Links